Ribeiro, T.; Jónsdóttir, K.; Hernandez-Bautista, R.; Silva, N.G.; Sánchez-Astráin, B.; Samadi, A.; Eiriksson, F.F.; Thorsteinsdóttir, M.; Ussar, S.; Urbatzka, R.
Metabolite Profile Characterization of Cyanobacterial Strains with Bioactivity on Lipid Metabolism Using In Vivo and In Vitro Approaches. Mar. Drugs 2023, 21, 498.
https://doi.org/10.3390/md21090498
AMA Style
Ribeiro T, Jónsdóttir K, Hernandez-Bautista R, Silva NG, Sánchez-Astráin B, Samadi A, Eiriksson FF, Thorsteinsdóttir M, Ussar S, Urbatzka R.
Metabolite Profile Characterization of Cyanobacterial Strains with Bioactivity on Lipid Metabolism Using In Vivo and In Vitro Approaches. Marine Drugs. 2023; 21(9):498.
https://doi.org/10.3390/md21090498
Chicago/Turabian Style
Ribeiro, Tiago, KristÃn Jónsdóttir, Rene Hernandez-Bautista, Natália Gonçalves Silva, Begoña Sánchez-Astráin, Afshin Samadi, Finnur F. Eiriksson, Margrét Thorsteinsdóttir, Siegfried Ussar, and Ralph Urbatzka.
2023. "Metabolite Profile Characterization of Cyanobacterial Strains with Bioactivity on Lipid Metabolism Using In Vivo and In Vitro Approaches" Marine Drugs 21, no. 9: 498.
https://doi.org/10.3390/md21090498
APA Style
Ribeiro, T., Jónsdóttir, K., Hernandez-Bautista, R., Silva, N. G., Sánchez-Astráin, B., Samadi, A., Eiriksson, F. F., Thorsteinsdóttir, M., Ussar, S., & Urbatzka, R.
(2023). Metabolite Profile Characterization of Cyanobacterial Strains with Bioactivity on Lipid Metabolism Using In Vivo and In Vitro Approaches. Marine Drugs, 21(9), 498.
https://doi.org/10.3390/md21090498